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Abstract: Glaucoma is the second most frequent cause of irreversible blindness worldwide. Genetic factors have 
been implicated in the development of the disease. So far six loci (GLCIA-GLCIF) and two genes 
(TIGRIMYOC and OPTN) arc involved in the development of juvenile (JOAG) and adult onset or chronic pri-
mary open angle glaucoma (COAG), while two loci (GLC3A,GLC313) and one gene (CYPIB1) are known for 
primary congenital glaucoma (PCG). Here we summarize the results of the first genetic studies of glaucoma in 
Costa Rica. Nine families: 1 with JOAG, 1 with PCG and 7 with COAG were screened for mutations at the 
known genes. A 10 bp duplication, 1546-1555dupTCATGCCACC, at the CYP1B1 gene, causes, in homozygous 
stale, glaucoma in the consanguineous PCG family. This mutation has been found in different countries and gen-
erates an early stop codon that termitates protein synthesis 140 amino acids earlier than the normal allele. In 
exon 1 of the TIGIUMYOC the innocuous Arg76Lys variant was found in two of the COAG families. In the 
OPTN gene two variants in the coding region (Thr34Thr, Met 98Lys) and 7 intronic changes were found in other 
Costa Rican glaucoma patients. One of the COAL families was chosen for a genome scan with 379 microsatel-
litc markers and linkage analysis. LOD scores "suggestive" of linkage were obtained for several chromosomal 
regions. Evidence indicates that hereditary glaucoma in Costa Rica is highly heterogeneous and that further 
studies in the country will probably disclose some up to now unknown genes responsible for the disease. Rev. 
Viol. Trip. 52(3): 507-520. Epub 2004 Dic 15. 
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Glaucoma is a clinically and genetically 
heterogeneous group of chronic eye diseases 
characterized by degeneration of the optic 
nerve head, a distinctive pattern of visual field 
loss, and a painless progression, usually associ-
ated with elevated intraocular pressure (Shields 
et al. 1996). Worldwide, it is the second most 
frequent cause of irreversible blindness in the 
age group of 40 years or older (Quigley 1996), 
and remarkably, Rodriguez et al. (2002) esti-
mated that glaucoma was the main cause of 
bilateral blindness in a group of "Hispanics", 
aged 40 years and older, residing in USA. 
The different kinds of glaucoma arc classi-
fied according to their etiology (primary versus  
secondary), to the anatomy of the anterior 
chamber of the eye (open angle versus closed 
angle) and to the age of onset (congenital, 
juvenile, adult) (Shields 1996). Primary open 
angle glaucoma (POAG) is the most frequent 
kind in Western countries (Shingleton et al 
1994), while in Orientals most cases are closed 
angle glaucomas (Lai et al 2001, Foster and 
Johnson 2001). Among the POAG, chronic 
open angle glaucoma (COAG) with an age of 
onset after the fourth decade of life, accounts 
for approximately half of all cases. The less 
frequent juvenile open angle glaucoma 
(JOAG) usually has a more severe phenotype 
with an age of onset between 3 and 30 years. 
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The also rare primary congenital glaucoma 
(PCG), sometimes referred to as buphthalmos, 
is congenital or manifests during the first 3 
years of age (Shields et al. 1996). 
EPIDEMIOLOGY AND GENETICS 
In general, epidemiological data for glau-
coma are vague. Several authors have reported 
prevalence rates which are impossible to com-
pare because of differences in diagnostic crite-
ria, in the ages of onset and the ethnic 
affiliation of the subjects studied. Thus, report-
ed prevalence figures from individuals with 
ages over 40 years range from 0.2% to 7%, 
with the highest values always found in Blacks 
(Dielemans et al. 1994, Leske et al. 1994, 
Ekstrom 1996, Wensor et al. 1998, Buhrmann 
et al. 2000, Quigley 2001, Racette et al. 2003). 
Quigley et al. (2001) estimated the prevalence 
of glaucoma in 4774 Hispanic subjects living 
in USA. They found an intermediate value 
(1.97%) between those reported for 
Caucasians and Afro-Americans. The age-spe-
cific prevalence in this population increased 
from 0.5% in the age group 41 to 49 years to 
12.63% in persons older than 80 years. 
Regarding incidence there is an even 
smaller number of studies, which, in addition, 
offer less reliability because their values have 
been estimated indirectly from the preva-
lences. A remarkable exception is the Barbados 
Eye Study where 3000 subjects of Subsaharan 
African ancestry older than 40 years and with-
out a previous diagnosis of glaucoma were 
prospectively followed up during a period of 4 
years. Incidence was estimated to be 0.55% 
per year. The risk was especially high for older 
adults, exceeding I% per year for the oldest 
age group (Leske et al. 2001). 
Incidence of open-angle glaucoma has 
been associated with several risk factors (Le 
2003). 	 Prevalence of the disease clearly 
increases with age (Leske et al. 1994, Klavcr et  
al. 1998, Leske et al. 2001, Quigley 2001, Le 
et al. 2003, Lee et al. 2003). However, con-
troversy exists for the role of elevated intraoc-
ular pressure as a risk factor, mainly because 
the levels of intraocular pressure at which a 
person develops disease vary greatly. Le et al. 
(2003) found no significant risk for intraocular 
pressure higher than 21 nun Hg, often consid-
ered the threshold value at which risk increas-
es (Shingleton et al. 1994), however they did 
find a higher mean intraocular pressure in 
glaucoma subjects than in controls. Genetic 
predisposition has been recognized for a long 
time as an important risk factor. Wolfs et a! 
(1998) found that prevalence of glaucoma, 
enlarged cup-disc ratio (one of the first signs of 
glaucoma), and elevated intraocular pressure 
are much higher in siblings and offspring of 
patients with glaucoma than in relatives of con-
trols and estimated that their lifetime risk of 
glaucoma was 10 limes higher than that of their 
healthy controls. The authors also estimate that 
a genetic component may underlie in at least 
one sixth of all glaucoma cases in the general 
population. In the Barbados Family Study 
Nemesure et al. (2001) examined 1056 rela-
tives from 207 open-angle glaucoma affected 
probands. Among them 10% clearly had open-
angle glaucoma and 13% could be affected 
(i.e., individuals showed some symptoms like 
visual field loss or disc pathology but did not 
meet all the diagnostic criteria for glaucoma). 
Besides the many sporadic cases, inheri-
tance of the disease, especially the COAGs 
also shows great variation (Wiggs et al. 2000). 
In some families it conforms to Mendelian 
segregation ratios whereas in others it presents 
complex patterns, i.e., they only show aggre-
gation of patients. Among the families w ith 
Mendelian inheritance, different modes of 
inheritance have been documented, but in 
most cases with COAG and JOAG the segre-
gation is autosomal dominant, while PCG fol-
lows a recessive pattern of inheritance 
(Sarfarazi 1997). 
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GENOMIC REGIONS AND 
GENES IDENTIFIED 
Mapping efforts, mainly linkage analyses, 
have lcd to the discovery of genomic regions 
(loci) and genes responsible for glaucomas with 
Mendelian patterns of inheritance. To date 6 
loci and 2 candidate genes have been identified 
for the autosomal dominantly inherited POAGs, 
2 further loci and mutations in one gene were 
found for congenital glaucoma (Table 1). 
Myocilin (MYOC, GLC I A) 
Shortly after the identification of the first 
candidate gene for primary open angle glauco-
ma, the "trabecular meshwork inducible gluco-
corticoid response" (TIGR) gene, the gene 
Myocilin (MYOC), was isolated from cDNA 
from human retina (Stone et al. 1997), cloned, 
characterized, and shown to be identical to 
TIGR (Kubota et al. 1997, Polansky et al. 
1997, Stone et al. 1997). Although more than 
100 potentially disease causing mutations have 
been identified in the TIGR/MYOC gene and 
remarkably, most of them located in exon 3 
(Human Gene Mutation Database Cardiff, 
HGMD), several large studies have shown that  
only 3 to 5% from POAG patients carry muta-
tions in the MYOC (GLC1A) gene (Michels-
Rautenstrauss et al. 1998, Fingert et al. 1999, 
Kubota et al. 2000, Michels-Rautenstrauss et 
al. 2002). 
TIGR/MYOC is expressed in the trabccu-
lar meshwork and its product, myocilin, is 
secreted into the aqueous humor. Very little to 
no myocilin was secreted in vitro from cells 
expressing five different mutant forms of 
MYOC, and no mutant myocilin was detected 
in the aqueous humor of patients with the most 
common mutation, GIn368Stop (Jacobson et 
al. 2001). Apparently mutant myocilin, lack-
ing the olfactomedin-like domain, is not cor-
rectly processed in the endoplasmic reticulum 
and accumulates into insoluble aggregates, 
The presence of increasing amounts of mutant 
protein induces a fraction of the soluble, native 
myocilin to move to the insoluble fraction 
(Caballero y Borras 2001). Interestingly, mice 
homozygous and heterozygous for a myocilin 
null mutation do not exhibit a pathological 
phenotype, indicating that a loss-of-function 
effect could not necessarily cause the glauco-
matous phenotype in humans (Tamm 2002). 
For a comprehensive review of the pathobiolo-
gy of MYOC refer to Tamm (2002). 
TABLE 1 
Chromosomal location and known genes for different twes of primary glaucomas 
l3. pc Name Locus Inheritance #OMIM* Gene References 
JOAG GLCIA 1q23-q25 AD" 601652 MYOC Sheffield et al. 1993, Stone et al. 1997, 
Polansky et al. 1997. Kubota et al 1997 
COAG GLC1B 2cen-ql3 Al) 606689 unknown Stoilova er al. 1996 
GLCIC 3q21-q24 Al) 601682 unknown Wirtz et al. 1997. Kilsos er al. 2001 
GLOB 8q23 Al) 602429 unknown Trifan er al. 1998 
GLC1E 10p15-p14 Al) 602432 OI'TN Sarfarazi et al. 1998, Re7ilie Cr al, 2002 
GLCIF 7q35-36 Al) 603383 unknown Wirtz et al. 1999 
PCG G LC3 A 421 AR"' 601771 CYPI131 Sarfarazi et al. 1995, Stoilov et al. 1997. 
liejlani cr al. 1998 
OLC313 1p36 AR 600975 unknown Akarsu et al. 1996 
`(OMIM 2004) 
"AD : autosomal dominant, ***AR : autosomal recessive: 
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Optineurin (OPTN, GLC1E) 
Linkage analysis of a single family with 
normal tension glaucoma (NTG) and patients 
with an age of onset between 23 and 65 years 
implicated a 21 cM region (GLC1E) on chro-
mosome 10p14-p15 (Sarfarazi et al. 1998). 
The OPTN gene, also known as FIP-2 (Li et al. 
1998) and as NRP (Schwambom et al. 2000), 
was later identified in this region (Rezaie et al. 
2002). Optineurin interacts with huntingtin 
(Faber et al. 1998), with the transcription fac-
tor ILIA (Moreland et al. 2000) and with 
RAB8, a GTPase involved in membrane trans-
port (Hattula and Peranen 2000). OPTN could 
belong to the tumor necrosis factor alpha 
(TNF-a) signal pathway and through loss of 
function due to mutation facilitate the induc-
tion of apoptosis (Li et al. 1998). 
A missense mutation Glu5OLys was iden-
tified in the original family. Later, Rezaie et al. 
(2002) discovered four additional variants 
after screening 54 families with autosomal 
dominant COAG which had at least one mem-
ber with normal tension. The authors found 
mutations in the OPTN gene in 16.7% from 
families with glaucoma presenting normal to 
moderately elevated intraocular pressure and 
considered a Met98Lys change in exon 5 as a 
"risk associated variant". However, subse-
quent studies with sporadic POAG patients 
have found this variant at very similar frequen-
cies in patients and controls, lending doubt 
about the putative morbidity of the amino acid 
change. The frequency of OPTN mutations in 
these sporadic patients' groups is very low, 
ranging from 0% to 1.6% in studies in USA, 
England and China (Aung et al. 2003, Leung et 
al. 2003, Wiggs et al. 2003). 
Cytochrome P450 1BI {CYPIBI, GLC3A) 
In PCG families from different ethnic 
groups with linkage to GLC3A several disease 
causing mutations were identified in the 
cytoehrome P450 1B1 (CYPIBI) gene 
(Stoilov et al. 1997,1998, Bejjani et al. 1998), 
one of the more than 300 members of the P450  
gene superfamily (Nebert et al. 1991, Sarfarazi 
1997, Stoilov et al. 2001). Mutations in this 
gene seem to be the main cause of familial 
PCG cases (Sarfarazi and Stoilov 2000). More 
than 50 disease causing mutations have been 
described (Bejjani et al. 1998, Stoilov et al. 
1998, Bejjani et a/. 2000, M ichels-
Rautenstrauss et al. 2001, Stoilov et al. 2002, 
Chavarria Soley et al. 2003), from which near-
ly 50% cause either a truncated protein, loss of 
the hem-binding domain coded in exon 3, or 
the loss of highly conserved amino acids with 
important functions. CYPIBI is believed to 
have a role in the normal development and 
function of the anterior eye chamber (Sarfarazi 
and Stoilov 2000, Stoilov et al. 2001). 
Other loci 
Wiggs et al. (2000) employed a two-step 
affected-sib-pair (ASP) analysis with 113 
ASPs with POAG from 41 families and 
obtained multipoint-lod-scores higher than 1 
for seven loci and higher than 2 for five loci. 
From the previously known loci only GLCIB 
in chromosome 2cen-q13 was confirmed, the 
rest of the regions with high scores were found 
for the first time in this study. A more recent 
study comprising 1327 individuals and 146 
families (the Barbados family study of Open 
Angle Glaucoma) did not find any linkage to 
the MYOC locus, but gave some evidence for 
chromosomes 1, 2, 9, 10, 11 and 14 (Nemesure 
et al. 2003). 
Summing up, the studies of familial glau-
coma have disclosed a significant genetic het-
erogeneity. A good number of the genes 
responsible for glaucomas are still to be dis-
covered. The genomc wide scans performed so 
far have begun to identify several "interesting" 
regions, where a gene responsible for glauco-
ma could be located. This indicates that a con-
siderable number of genes must be implicated 
in the delicate patterns of eye development and 
in the complexity of the regulatory mecha-
nisms of eye homeostasis; the heterogeneity is 
thus explained if mutations at all these genes 
alter the normal ocular physiology. Therefore, 
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from an evolutionary perspective it is not sur-
prising to find not only ethnic-specific mutated 
genes and private glaucoma causing alleles but 
also alleles specific to geographic areas where 
human expansion has recently originated (and 
still originates) new populations. Interethnic 
admixture, breaking of isolates plus de novo 
mutation might have produced interesting 
combinations of susceptibility alleles for glau-
coma, and other diseases, in these places, an 
evolutionary situation worth studying. The 
countries of the New World are among the 
ones where this possibility can be tested. 
GLAUCOMA IN COSTA RICA 
The study of glaucoma in Costa Rica 
began in the year 2000 as a result from an ear-
lier cooperation between geneticists of the 
School of Biology and INISA, University of 
Costa Rica and of the Institute of Human 
Genetics from the Friedrich-Alexander 
University of Erlangen-Nuremberg, Germany. 
Its main goals are the genetic and molecular 
characterization of primary glaucomas in 
Costa Rica. Contact to the patients was possi-
ble thanks to the collaboration of ophthalmol-
ogists who were willing to participate in the 
project and who kept records of familial glau-
coma. To consider a case as familial, there 
must be at least a second affected person in the 
family besides the propositus, and the disease 
must be present in at least two generations. A 
total of 9 families with glaucoma complied 
with these requirements; seven of them present 
COAG, one has JOAG and one has PCG. The 
age of onset in the COAG families varied from 
40 to 70 years old, however a great concor-
dance among the members of each family was 
the rule. 
The patients were contacted and, after 
informed consent, pedigrees from the families 
were constructed and DNA was extracted from 
peripheral blood. DNA extraction was per-
formed at INISA after standard salting out 
methods (Miller 1988). The molecular study 
was performed in Erlangen, Germany. The first  
logical step was to rule out CYP I B1 mutations 
in the PCG family and TIGR/MY0C as well as 
OPTN mutations in the COAG and MAC 
families. 
PRIMARY CONGENITAL 
GLAUCOMA FAMILY 
The PCG family presents consanguinity 
and the disease follows an autosomal recessive 
mode of inheritance (Fig. I). Four members of 
the family are affected. Two of the patients arc 
brothers (V:8 and V:9); their parents are sec-
ond cousins. The third patient (V:7) is a little 
bit more than a first cousin on both sides of the 
affected brothers (their mothers are sisters and 
their fathers are brothers), therefore he is also 
son of a consanguineous mating between sec-
ond cousins. The two brothers have classical 
congenital glaucoma, already present at birth, 
with the typical signs of tearing, light sensitiv-
ity, cloudiness of the cornea, and enlargement 
of the eye. They have experienced several sur-
geries in both eyes. In contrast, their affected 
cousin has a milder form of the disease pre-
senting the first symptoms at the age of 9 years 
old, however with the symptoms of congenital 
glaucoma and has not required surgery. 
Individual 111:3 is also affected with glaucoma, 
though with an age of onset after the age of 50. 
The affected members of the family were 
screened for mutations in CYPIBI. A 10 base 
pair homozygous duplication (1546-1555dup 
TCATGCCACC) (Fig. 2.) was discovered in 
exon 3 of individuals V:7, V:8 and V:9. The 
gene was then sequenced for all available fam-
ily members. Both pairs of parents of the three 
affected boys are heterozygous for this dupli-
cation which they inherited from their mothers 
(II1-1 and 111-4). Other members of the family, 
IV-I, IV-10 and V-6 are also heterozygous, as 
can be seen in figure 1. 
This duplication causes an early stop 
codon that results in a protein which is 140 
amino acids shorter than the normal version. 
The truncated protein lacks the functionally es-
sential heme-binding site. The mutation was 
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Fig. 2. Electropherogrants for gene CYP I B1 in the PCG family with the duplication 1546-
1555dupTCATGCCACC. (A) Normal sequence, (B) Homozygous duplication, (C) Heterozygous 
duplication. The bars on top of the sequences represent the duplicated region. The Gcnllank U03688 
sequence was used as reference. 
A 
B 
was not inherited from him. This suggests that 
III-3 surely is a sporadic case. 
TIGR/MYOC and OPTN screening 
TIGR/MYOC and OPTN were both ini-
tially sequenced in one affected patient from 
each of the COAG families and both individu-
als with later onset from the PCG family, as 
well as in a healthy control. The Arg76Lys 
variant in cxon 1 of the TIGR/MYOC gene was  
found in patients from two of the COAG fam-
ilies. This allele was not found in the control. 
The rest of the affected individuals and sever-
al healthy members from each of these families 
were screened for mutations in this gene to get 
insight on the role of this variant in the patho-
genesis of the disease in these families. The 
Arg76Lys variant was found in 7 affected and 3 
healthy persons. Reports show that this allele 
has often been found in glaucoma patients as 
well as in healthy controls (Stoilova et al. 1998, 
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Fingert et al. 1999, Kubota et al. 2000, Lam et 
al. 2000, Shimizu et al. 2000, Mabuchi et aL 
2001, Michels-Rautenstrauss et al. 2002, 
Forsman et aL 2003, Melki et al. 2003). Thus, it 
is considered an innocuous variant. 
Sequencing the 13 coding exons of the 
OPTN gene disclosed 7 variants in the introns 
of the gene and 2 in the exons. The base sub-
stitutions in the introns do not interfere with 
splicing. The two variants in the coding 
sequence are, first, the Met98Lys in exon 5 
only found in one individual in the PCG family 
(already discussed) and, second, a synonymous 
Thr34Thr substitution in exon 4 which with 
high probability does not cause the disease. 
LINKAGE ANALYSIS 
In summary, all of the genes known so far 
as involved in the pathogenesis of glaucoma 
can be discarded as the cause of the disease in 
the COAG patients of Costa Rica. Therefore, 
the next step was to look for other genomic 
regions where the responsible mutations can 
be found, however, only one of the seven 
COAG families (Fig. 3) complies with the 
requirements for a linkage analysis, there are 
affected members in three generations, with 
the affected individuals still alive in two of the 
generations, a total of eight affected persons 
and an autosomal dominant pattern of inheri-
tance. A LOD score simulation revealed that a 
maximum value of 3.59 could be reached under 
ideal conditions. Thus this family was chosen  
for a genome scan with 379 microsatcllite 
markers, which presented an average heterozy-
gosity of 0,63. The statistical analysis disclosed 
several regions with LOD scores "suggestive" 
of linkage (Chavarria-Soley 2003), which are 
being further evaluated with SNPs with the 
goal of mapping the location of the gene 
responsible for glaucoma in the family. 
GLAUCOMA IN COSTA RICA. 
PRELIMINARY CONCLUSIONS 
AND PERSPECTIVES 
The first results of the characterization of 
the molecular and genetic bases of glaucoma 
in Costa Rica allow one conclusion: glaucoma 
seems to have a highly heterogeneous genetic 
background in the country. Besides the dupli-
cation in CYPIBI (1546-1555dupTCATGC-
CACC) found in the Costa Rican PCG family, 
a mutation also reported in individuals from 
USA, Turkey, England, Germany and Brazil, 
no other known mutation has been found in 
any other Costa Rican familial case studied so 
far in genes identified elsewhere as responsi-
ble for the disease. This is a not a surprising 
finding. Glaucoma, especially POAG, has 
been shown to be a genetically heterogeneous 
disease. In addition, the genes involved in 
POAG identified so far are responsible for 
very few of the glaucoma cases. In large num-
bers of sporadic glaucoma patients the 
TIGRIMYOC gene is mutated in only 3 to 
7.5% of the cases (Stone et al. 1997, Suzuki et 
11:1 	 112 113 	 11:4 
li 	 1111▪ 	 111:4 111:5 	 .11t ---f; I. 	 6 	 6 111'11 111:12 11133 111:14 	 111:15 111:16 111:17 
1V.1 7 IVaa IV 19 1V:20 14 21 
O 6 	 6 	 6 4 6 • 6 6 
1V:2 1 3 IV.4 1V:5 1V:6 IV 7 iVit IV2 IV:10 IV II 1V:12 1V:13 1V:14 I :15 IV 16 
Fig. 3. Pedigree of the COAG Costa Rican family chosen for linkage analysis. 
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al. 1997, Alward et a1.1998, Fingert et al. 
1999, Kubota et aL 2000, Shimizu et al. 2000, 
Michels-Rautenstrauss et al. 2002, Melki e al. 
2003). The more recently identified OPTN is 
also responsible for less than 2% of sporadic 
POAG cases (Aung et al. 2003, Leung et al. 
2003, Wiggs et al. 2003). 
Given these facts and in the context of the 
interethnic admixture and expansion of the 
Costa Rican population, it is very likely that 
some, maybe several, up to now unknown 
genes are involved in the pathology of the dis-
ease in this land. Many of these genes surely 
are the same causing the disease in other coun-
tries and they were introduced in Costa Rica by 
the interethnic gene flow process initiated dur-
ing the conquest of the American continent by 
the Europeans. This process has delineated a 
Costa Rican population with a main trihybrid 
ancestry, resulting from the cumulative admix-
ture of genes of European (61%), Amerindian 
(30%) and African (9%) origin (Morera et al. 
2003). The different regions of the country 
have a very similar hybrid structure with slight 
variations among them (Madrigal et aL 2001, 
Morera et al. 2001, 2003). 
From this perspective. Costa Rica offers 
the opportunity to identify and characterize 
several genes involved in glaucoma. However, 
some methodological considerations must be 
kept in mind in order to guarantee success in 
the next stages of the venture. Gene mapping is 
a statistic-dependent process, as such relies on 
meeting the requirements of the method 
employed to estimate the significance of the 
association of a phenotype with a chromoso-
mal region. The linkage analysis with the 
COAG family disclosed several regions where 
the gene responsible for glaucoma could 
potentially be located, but no definite linkage 
was found. The lack of a statistical linkage of 
the phenotypes with any marker, contrary to 
the expectations after the simulations (see 
above), can be duc to an insufficient number of 
affected individuals in the family and the fact 
that the eight living persons suffering  
glaucoma are in two generations, or even a 
polygenic inheritance with phenocopies. 
The average heterozygosity value of 0.63 
showed by the set of microsatellite markers 
used, is lower than values from other genome 
scans which range from 0.76 to 0.8 (Kuokkanen 
et al. 1997, Lee et al. 2000, Wiltshire et aL 
2001). This could reflect a reduced heterozy-
gosity in the Costa Rican population for these 
microsatellites, or simply be due to the fact that 
the value is based on data from only 30 persons 
from one family. Unfortunately there is current-
ly no information on allele-frequencies, i.e. an 
estimation of information content, heterozygos-
ity, background linkage disequilibrium, etc., of 
the markers employed in mapping projects for 
the Costa Rican population. Such data, stratified 
by region, would permit a better marker selec-
tion for mapping efforts in the country. 
The advent of a new technologies which 
allow the rapid typing of thousands of SNPs 
have made large-scale, whole-genome associa-
tion studies feasible. In Costa Rica, as well as 
in the rest of the world, the most frequent glau-
coma cases are sporadic (single, or simplex 
patients for which a family history is known 
but no other affected relatives are available). 
A future stage in our project would include the 
collection of a large group of such cases and 
their respective controls, which must first be 
screened for mutations at known glaucoma 
genes. If these genes are discarded as responsi-
ble of the affection, these patients and controls 
could be included in an association analysis 
using SNPs as markers. This would also 
require, as is the case for microsatellites, 
knowledge of allelic frequencies in the Costa 
Rican population. This knowledge would 
allow to determine the minimal conditions to 
be met by the families in linkage analyses and 
to estimate how suitable the Costa Rican pop-
ulation is for association studies, a very impor-
tant subject especially in attempts to map loci 
involved in complex traits. In any case, the 
genetic study of glaucoma in Costa Rica has 
begun to open new research perspectives. 
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RESUMEN 
El glaucoma es la segunda causa de ceguera irrever-
sible en el mundo. El componente genetic° de algunos de 
los distintos tipos ha sido demostrado: seis loci (GLC1A-
GLC1F) y dos genes (TIGNMY0C y OPTN) se conocen. 
hasta ahora, como responsables de la aparicion de glauet)--
mas primarios de angulo abierto tanto del tipo juvenil 
(JOAG) como del tipo de adultos (COAG). Ademas, dos 
loci (GLC3A,GLC3B) y un gene (CYPIBI) se hen descu-
bierto coma causal del tipu primariu congenito (PCG). Sc 
presenta una relaciort de los estudios geneticos iniciales 
sobre el glaucoma en Costa Rica. Nueve families: 1 con 
JOAG, 1 con PCG y 7 con COAG se estudiaron en bused 
de mutaciones en los genes conocidos. Una duplicaciOn 
de 10 ph, 1546-1555dupTCATGCCACC, en el gene 
CYPIBI, causa glaucoma en condicionhornocigraa cn una 
fatutliaconsaguinca con PCG. Esta mutation se ha encon-
trado en otros paises y origins un codon dc terminacion 
prematuro que codifica una proteins 140 aminoacidos mas 
cotta que la normal. En dos de las families eon COAG 
encondo tins variante inocua Arg76Lys en el exon I del 
gen TIGR/MYOC. Otros pacienies prescntaron. en el gene 
OPTN, dos variantes en la region codificarne (Thr34Thr. 
Met 9SLys) y 7 cambios intrOnicos. Una de las familia.; 
con COAG cumple con los requerimientos minimos parr 
tut anilisis de ligamicnto, por lo que sc utilizaron 379 mar-
cadores microsateliticos pars mapear el gen causante de Is 
enfermedad. No sc obtuvieron valores LOD quc elaramen-
te impliearan a alguna region criamosamica. La evidencia 
senala que el glaucoma hereditario en Costa Rica tiene una 
gran heterogeneidad gcnetica y quc es muy posible que los 
estudios que sc desarrollan vayan a descubrir nuevos genes 
involucrados en la patologia. 
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